Covid 19
Research payments
$1,112,333
Through program year 2023, $1,112,333 in research payments was reported against Covid 19, across 27 payments.
- Paid by (largest first)
- Rigel Pharmaceuticals, Inc.; Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $75,733 | 3 |
| 2022 | Research | $246,652 | 2 |
| 2021 | Research | $789,949 | 22 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Anuj Malik Tulsa, OK Named on 9 payments
- Leorah Freeman Austin, TX Named on 6 payments
- Deepa Gotur Houston, TX Named on 5 payments
- Gyorgy Frendl Boston, MA Named on 3 payments
- Amit Goyal Elk Grove Village, IL Named on 2 payments
- Jason Wells Portland, OR Named on 1 payment
- Alpesh Amin Orange, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.